Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials

Vikki A. McBain, Anthony G. Robson, Chris R. Hogg, Graham E. Holder

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background The aim of the study was to validate the use of the short duration pattern onset visual evoked potential (PappVEP) in the objective assessment of visual acuity (VA) in patients referred with presumed non-organic visual loss.

Methods The combination of minimum check size and minimum contrast required to elicit a consistently discernible PappVEP (amplitude >= 5 lLV) were measured in ten normal subjects under conditions of induced optical blur (0 to +3 dioptres) and the relationship to Snellen VA established. The data from 100 consecutive patients (167 eyes) referred for possible non-organic visual loss (NOVL) and 20 patients with confirmed visual pathway dysfunction were reviewed in relation to the results in normal subjects.

Results Snellen VA, under conditions of blur, could be predicted in normal subjects from the check size and contrast required to elicit a criterion PappVEP. These data were tabulated and a quantitative guideline established for the estimation of VA in the patients referred with suspected NOVL. Most (88%) patients referred with suspected NOVL had normal electrophysiology and PappVEPs consistent with normal Snellen VA. In others, they suggested a degree of non-organic overlay. In 20 cases of organic visual loss.

Conclusions The short duration pattern onset visual-evoked potential is confirmed as a clinically useful tool in the objective assessment of patients with suspected non-organic visual loss.

Original languageEnglish
Pages (from-to)502-510
Number of pages9
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume245
Issue number4
Early online date17 Nov 2006
DOIs
Publication statusPublished - Apr 2007

Keywords

  • non-organic visual loss
  • onset-offset
  • optical blur
  • VEPs
  • visual acuity
  • snellen acuity
  • objective assessment
  • contrast
  • children
  • VEPS
  • diagnosis
  • responses
  • standard
  • hysteria
  • system

Cite this

Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials. / McBain, Vikki A.; Robson, Anthony G.; Hogg, Chris R.; Holder, Graham E.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 245, No. 4, 04.2007, p. 502-510.

Research output: Contribution to journalArticle

@article{5233376c9f254a0392529ffe965186e4,
title = "Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials",
abstract = "Background The aim of the study was to validate the use of the short duration pattern onset visual evoked potential (PappVEP) in the objective assessment of visual acuity (VA) in patients referred with presumed non-organic visual loss.Methods The combination of minimum check size and minimum contrast required to elicit a consistently discernible PappVEP (amplitude >= 5 lLV) were measured in ten normal subjects under conditions of induced optical blur (0 to +3 dioptres) and the relationship to Snellen VA established. The data from 100 consecutive patients (167 eyes) referred for possible non-organic visual loss (NOVL) and 20 patients with confirmed visual pathway dysfunction were reviewed in relation to the results in normal subjects.Results Snellen VA, under conditions of blur, could be predicted in normal subjects from the check size and contrast required to elicit a criterion PappVEP. These data were tabulated and a quantitative guideline established for the estimation of VA in the patients referred with suspected NOVL. Most (88{\%}) patients referred with suspected NOVL had normal electrophysiology and PappVEPs consistent with normal Snellen VA. In others, they suggested a degree of non-organic overlay. In 20 cases of organic visual loss.Conclusions The short duration pattern onset visual-evoked potential is confirmed as a clinically useful tool in the objective assessment of patients with suspected non-organic visual loss.",
keywords = "non-organic visual loss, onset-offset, optical blur, VEPs, visual acuity, snellen acuity, objective assessment, contrast, children, VEPS, diagnosis, responses, standard, hysteria, system",
author = "McBain, {Vikki A.} and Robson, {Anthony G.} and Hogg, {Chris R.} and Holder, {Graham E.}",
year = "2007",
month = "4",
doi = "10.1007/s00417-006-0431-2",
language = "English",
volume = "245",
pages = "502--510",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials

AU - McBain, Vikki A.

AU - Robson, Anthony G.

AU - Hogg, Chris R.

AU - Holder, Graham E.

PY - 2007/4

Y1 - 2007/4

N2 - Background The aim of the study was to validate the use of the short duration pattern onset visual evoked potential (PappVEP) in the objective assessment of visual acuity (VA) in patients referred with presumed non-organic visual loss.Methods The combination of minimum check size and minimum contrast required to elicit a consistently discernible PappVEP (amplitude >= 5 lLV) were measured in ten normal subjects under conditions of induced optical blur (0 to +3 dioptres) and the relationship to Snellen VA established. The data from 100 consecutive patients (167 eyes) referred for possible non-organic visual loss (NOVL) and 20 patients with confirmed visual pathway dysfunction were reviewed in relation to the results in normal subjects.Results Snellen VA, under conditions of blur, could be predicted in normal subjects from the check size and contrast required to elicit a criterion PappVEP. These data were tabulated and a quantitative guideline established for the estimation of VA in the patients referred with suspected NOVL. Most (88%) patients referred with suspected NOVL had normal electrophysiology and PappVEPs consistent with normal Snellen VA. In others, they suggested a degree of non-organic overlay. In 20 cases of organic visual loss.Conclusions The short duration pattern onset visual-evoked potential is confirmed as a clinically useful tool in the objective assessment of patients with suspected non-organic visual loss.

AB - Background The aim of the study was to validate the use of the short duration pattern onset visual evoked potential (PappVEP) in the objective assessment of visual acuity (VA) in patients referred with presumed non-organic visual loss.Methods The combination of minimum check size and minimum contrast required to elicit a consistently discernible PappVEP (amplitude >= 5 lLV) were measured in ten normal subjects under conditions of induced optical blur (0 to +3 dioptres) and the relationship to Snellen VA established. The data from 100 consecutive patients (167 eyes) referred for possible non-organic visual loss (NOVL) and 20 patients with confirmed visual pathway dysfunction were reviewed in relation to the results in normal subjects.Results Snellen VA, under conditions of blur, could be predicted in normal subjects from the check size and contrast required to elicit a criterion PappVEP. These data were tabulated and a quantitative guideline established for the estimation of VA in the patients referred with suspected NOVL. Most (88%) patients referred with suspected NOVL had normal electrophysiology and PappVEPs consistent with normal Snellen VA. In others, they suggested a degree of non-organic overlay. In 20 cases of organic visual loss.Conclusions The short duration pattern onset visual-evoked potential is confirmed as a clinically useful tool in the objective assessment of patients with suspected non-organic visual loss.

KW - non-organic visual loss

KW - onset-offset

KW - optical blur

KW - VEPs

KW - visual acuity

KW - snellen acuity

KW - objective assessment

KW - contrast

KW - children

KW - VEPS

KW - diagnosis

KW - responses

KW - standard

KW - hysteria

KW - system

U2 - 10.1007/s00417-006-0431-2

DO - 10.1007/s00417-006-0431-2

M3 - Article

VL - 245

SP - 502

EP - 510

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 4

ER -